Events Eleventh International Pharmaceutical and Medical Device Compliance… Thomas Sullivan Mar 1, 2017 0 The Eleventh International Pharmaceutical and Medical Device Compliance Congress will be held May 15 - 17, 2017 at the Lisbon…
Executive Branch Trump Executive Order Targets Regulations Thomas Sullivan Feb 28, 2017 0 On one of his first few days on the job, President Donald Trump signed an executive order that would require all government…
Compliance Qordata Hosting Compliance Insights Webinar March 1 Thomas Sullivan Feb 28, 2017 0 On Wednesday, March 1, 2017, qordata is hosting a webinar, titled, “Making Analytics Work at Merck USA.” The webinar features…
CMS Senate Finance Committee Hearing on Seema Verma Confirmation Thomas Sullivan Feb 27, 2017 0 On February 16, 2017, the Senate Finance Committee held a hearing to discuss the nomination of Seema Verma to be the Administrator…
FDA FDA’s Meeting on Promotion – Can We Glimpse the Future? Thomas Sullivan Feb 27, 2017 0 In November, the FDA held a two-day Town Hall meeting to allow for input from stakeholders and patients surrounding…
CMS Medical Device Parallel Review Program Made Permanent Thomas Sullivan Feb 24, 2017 0 A few months back, the U.S. Food and Drug Administration and the Centers for Medicare & Medicaid Services announced they are…
HHS-OIG Are the Safe Harbors Still Safe? – OIG Issues Final Rule Thomas Sullivan Feb 24, 2017 0 The Department of Health and Human Services Office of Inspector General published a final rule, after considering various…
CMS Providers May Have More Time to Submit Electronic Clinical Quality Measures Thomas Sullivan Feb 23, 2017 0 Eligible hospitals and critical access hospitals participating in the Hospital Inpatient Quality Reporting program and/or the…
FDA Citizens Petition Challenges FDA’s Off-Label Rule Thomas Sullivan Feb 22, 2017 0 On February 8, 2017, three organizations called on the United States Food and Drug Administration (FDA) to overhaul a newly…
Life Science Compliance Update Valeant and Philidor Controversy Comes to a Head Thomas Sullivan Feb 22, 2017 0 Valeant Pharmaceuticals, Inc. has had quite the year - they have been under scrutiny since October 2015. However, in November…